Improving Breast Cancer Disparities: Screening and Diagnosis
In this workshop, Dr. Nan Chen from the University of Chicago Medicine discusses screening and mammography rates among racial/ethnic groups. Dr. Chen also touches on the impact of the COVID-19 pandemic, factors that influence disparities such as fears and misperceptions, the underutilization of genetic counseling and testing, and the importance of patient communication and navigation. Learn how you can address disparities in your own patient care.
Medium: Online Presentation
Commercial Support: Support for this activity has been provided through educational grants from Daiichi Sankyo and Astra Zeneca
Sponsored by the University of Chicago Comprehensive Cancer Center, the University of Chicago Center for Continuing Medical Education, University of Illinois Chicago Cancer Center and their Chicago Cancer Screening and Testing Access Coalition (CCSTAC), and the Academy for Continued Healthcare Learning (ACHL).
At the conclusion of this activity, participants will be able to:
- Describe racial and ethnic differences in screening mammography and diagnosis of breast cancer;
- Recall the social determinants of health that may contribute to disparities in the diagnosis of breast cancer;
- Discuss the principles of patient navigation and support that can be implemented to address disparities in the screening and diagnosis of breast cancer.
Assistant Professor, Breast Medical Oncology
The University of Chicago
As a provider accredited by the ACCME, The University of Chicago Pritzker School of Medicine asks everyone in a position to control the content of an education activity to disclose all financial relationships with any ineligible companies. This includes any entity whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. Financial relationships are relevant if a financial relationship, in any amount, exists between the person in control of content and an ineligible company during the past 24 months, and the content of the education is related to the products of an ineligible company with whom the person has a financial relationship. Mechanisms are in place to identify and mitigate any relevant financial relationships prior to the start of the activity.
Additionally, The University of Chicago Pritzker School of Medicine requires Authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration at first mention and where appropriate in the content.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of Chicago Pritzker School of Medicine and the Academy for Continue Healthcare Learning (ACHL). The University of Chicago Pritzker School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.
Other healthcare professionals will receive a Certificate of Participation. For information on the applicability and acceptance of Certificates of Participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by the ACCME, please consult your professional licensing board.